WHAT’S TRENDING
-
Innovation at BD
The Future and InnovationDiscover how we’re innovating to drive better outcomes for patients at critical moments throughout their livesLearn more
-
NEWS
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial ResultsLearn MoreStrong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic Q4 GAAP and adjusted diluted EPS from...
-
NEWS
BD Board Increases Dividend for 53rd Consecutive YearLearn MoreThe Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an increase of 9.5% from the previous quarter. The dividend...
-
News
Patterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022Learn more